Search results for "Cerebro"

showing 10 items of 539 documents

Defective carbohydrate metabolism in multiple sclerosis

2015

La esclerosis múltiple (EM) es una enfermedad crónica del sistema nervioso central (SNC) en el que episodios repetidos de inflamación (bortes), dan lugar a inflamación que conduce a la interrupción de la vaina de mielina por daños producidos en la misma. Junto a este fenómeno de inflación focal, existe una inflamación difusa en el SNC, que unida a la anterior, dará lugar a que aparezca un proceso de neurodegeneración, que será el responsable último de la afectación axonal y neuronal difusa que es la que va a condicionar la discapacidad en los pacientes afectos de EM. La enfermedad es una causa importante de discapacidad neurológica y de disfunción neurológica en adultos jóvenes que afecta a…

Multiple Sclerosisneurodegenerative diseasebrain glucose metabolismIntermediate MetabolismMolecular Neurosciencerelapsing-remitting multiple sclerosiscerebrospinal fluid
researchProduct

Algorithms for the inference of causality in dynamic processes: Application to cardiovascular and cerebrovascular variability

2015

This study faces the problem of causal inference in multivariate dynamic processes, with specific regard to the detection of instantaneous and time-lagged directed interactions. We point out the limitations of the traditional Granger causality analysis, showing that it leads to false detection of causality when instantaneous and time-lagged effects coexist in the process structure. Then, we propose an improved algorithm for causal inference that combines the Granger framework with the approach proposed by Pearl for the study of causality among multiple random variables. This new approach is compared with the traditional one in theoretical and simulated examples of interacting processes, sho…

Multivariate statisticsProcess (engineering)Computer scienceBiomedical EngineeringInferenceHealth InformaticsMachine learningcomputer.software_genreHeart RateEconometricsHumansArterial PressureComputer Simulation1707Granger causality analysisSeries (mathematics)business.industryBrainHeartCausalityCausalityCerebrovascular CirculationCausal inferenceSignal ProcessingSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaArtificial intelligencebusinesscomputerRandom variableAlgorithms2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
researchProduct

Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium.

2009

N-methyl-d-aspartate receptor (NMDA-R)-mediated oxidative stress has been implicated in blood-brain barrier (BBB) disruption in a variety of neuropathological diseases. Although some interactions between both phenomena have been elucidated, possible influences of reactive oxygen species (ROS) on the NMDA-R itself have so far been neglected. The objective of this study was to examine how the cerebroendothelial NMDA-R is affected by exposure to oxidative stress and to assess possible influences on BBB integrity. RT-PCR confirmed several NMDA-R subunits (NR1, NR2B-D) expressed in the bEnd3 cell line (murine cerebrovascular endothelial cells). NR1 protein expression after exposure to ROS was ob…

N-MethylaspartateEndotheliumBlotting WesternGlutamic AcidStimulationApoptosismedicine.disease_causeBlood–brain barrierBiochemistryReceptors N-Methyl-D-AspartateImmunoenzyme Techniqueschemistry.chemical_compoundMicePhysiology (medical)medicineAnimalsRNA MessengerCells Culturedchemistry.chemical_classificationReactive oxygen speciesChemistrySuperoxideReverse Transcriptase Polymerase Chain ReactionCell biologyOxidative Stressmedicine.anatomical_structurenervous systemBiochemistryBlood-Brain BarrierCerebrovascular CirculationNMDA receptorEndothelium VascularReactive Oxygen SpeciesPeroxynitriteOxidative stressFree radical biologymedicine
researchProduct

Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España

2021

Describir las características clínicas de los pacientes tratados con evolocumab, las razones del inicio de la terapia y los efectos del tratamiento en la fase inicial de disponibilidad de evolocumab en las unidades de nefrología de España.

NefrologiaMalalties cerebrovascularsCor Malalties
researchProduct

The Role of Erythropoietin in Neuroprotection: Therapeutic Perspectives

2007

Nervous system diseases are very complex conditions comprising a large variety of local and systemic responses. Several therapeutic agents interfering with all or in part the biochemical steps that ultimately cause neuronal death have been demonstrated to be neuroprotective in preclinical models. However, all the agents so far investigated have inexorably failed in the phase III trials carried out. A large body of evidence suggests that the hormone erythropoietin (EPO), besides its well-known hematopoietic action, exerts beneficial effects in the central nervous system. EPO's effect has been assessed in several experimental models of brain and spinal cord injury thus becoming a serious cand…

Nervous systemEXPERIMENTAL SUBARACHNOID HEMORRHAGECentral nervous systemSIGNAL-TRANSDUCTIONPharmacologyModels BiologicalNeuroprotectionErythropoietin in neuroprotectionNEURONAL APOPTOSISCEREBROSPINAL-FLUIDAnimalsHumansMedicineIN-VIVO EVIDENCEErythropoietinSpinal cord injuryPharmacologyCEREBRAL-ISCHEMIACOMMON BETA-SUBUNITbusiness.industryRECOMBINANT-HUMAN-ERYTHROPOIETIN; GLYCOGEN-SYNTHASE KINASE-3-BETA; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; COMMON BETA-SUBUNIT; IN-VIVO EVIDENCE; CEREBRAL-ISCHEMIA; SIGNAL-TRANSDUCTION; CEREBROSPINAL-FLUID; NEURONAL APOPTOSIS; CYTOKINE RECEPTORSRECOMBINANT-HUMAN-ERYTHROPOIETINmedicine.diseaseRecombinant ProteinsEnzyme ActivationStrokeClinical trialNeuroprotective AgentsTreatment Outcomemedicine.anatomical_structureErythropoietinGLYCOGEN-SYNTHASE KINASE-3-BETACYTOKINE RECEPTORSBone marrowMitogen-Activated Protein Kinasesbusinessmedicine.drugDrug News & Perspectives
researchProduct

Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody–positive autoimmune encephalitis under imm…

2020

Neurological immune-mediated side effects are rare but often severe complications of immune checkpoint inhibitor (ICI) treatment. This report describes a severe case of nivolumab/ipilimumab-associated glutamic acid decarboxylase 65-positive autoimmune encephalitis. It proposes neurofilament light chain levels, a biomarker indicating axonal damage, in the cerebrospinal fluid and serum as a putative novel biomarker for this diagnostically and therapeutically challenging entity with an often unfavorable outcome. Additionally, we provide an overview of previous reports of patients developing autoimmune encephalitis under ICI treatment.

NeurofilamentGlutamate decarboxylaseIntermediate Filaments610 MedizinHashimoto Disease03 medical and health sciences0302 clinical medicineCerebrospinal fluid610 Medical sciencesHumansMedicine030212 general & internal medicineImmune Checkpoint InhibitorsAutoimmune encephalitisbiologyGlutamate Decarboxylasebusiness.industrymedicine.diseaseIpilimumabNivolumabNeurologyImmunologybiology.proteinEncephalitisBiomarker (medicine)Neurology (clinical)AntibodyNivolumabbusiness030217 neurology & neurosurgeryEncephalitisEuropean Journal of Neurology
researchProduct

Endothelial NT-3 Delivered by Vasculature and CSF Promotes Quiescence of Subependymal Neural Stem Cells through Nitric Oxide Induction

2014

SummaryInteractions of adult neural stem cells (NSCs) with supportive vasculature appear critical for their maintenance and function, although the molecular details are still under investigation. Neurotrophin (NT)-3 belongs to the NT family of trophic factors, best known for their effects in promoting neuronal survival. Here we show that NT-3 produced and secreted by endothelial cells of brain and choroid plexus capillaries is required for the quiescence and long-term maintenance of NSCs in the mouse subependymal niche. Uptake of NT-3 from irrigating vasculature and cerebrospinal fluid (CSF) induces the rapid phosphorylation of endothelial nitric oxide (NO) synthase present in the NSCs, lea…

Nitric Oxide Synthase Type IIICell SurvivalNeuroscience(all)BiologyNitric OxideNitric oxidechemistry.chemical_compoundMiceCerebrospinal fluidNeural Stem CellsNeurotrophin 3Subependymal zoneAnimalsCells CulturedCell ProliferationNeuronsGeneral NeuroscienceEndothelial CellsCell DifferentiationNeural stem cellCell biologynervous systemchemistrybiology.proteinPhosphorylationChoroid plexusStem cellNeuroscienceNeurotrophinNeuron
researchProduct

New neurons follow the flow of cerebrospinal fluid in the adult brain

2006

Autores: Sawamoto, K. et al. .- PMID:16410488

Olfactory systemRecombinant Fusion ProteinsSubventricular zoneNerve Tissue ProteinsBiologyCerebral VentriclesLateral ventriclesMiceCerebrospinal fluidNeuroblastCell MovementNeuroblast migrationEpendymamedicineAnimalsBrain Tissue TransplantationCiliaCerebrospinal FluidNeuronsMultidisciplinaryCell PolarityEpithelial CellsAnatomyOlfactory BulbOlfactory bulbmedicine.anatomical_structurenervous systemChoroid PlexusIntercellular Signaling Peptides and ProteinsNeuronNeuroscience
researchProduct

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay

2021

The discovery of new biomarkers for Alzheimer's disease (AD) is essential for an accurate diagnosis, to conceive new strategies of treatments, and for monitoring the efficacy of potential disease-modifying therapies in clinical trials. proNGF levels in the cerebrospinal fluid (CSF) represent a promising diagnostic biomarker for AD, but its validation was hampered by the absence of a reliable immunoassay. In the literature, proNGF is currently measured in postmortem brain tissue by semiquantitative immunoblot. Here we describe the development and validation of a new method to measure proNGF in the CSF of living patients. This method, based on molecular size separation by capillary electropho…

OncologyAgingmedicine.medical_specialtydiagnosisCognitive NeuroscienceNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseSettore BIO/09 - FisiologiaCerebrospinal fluidneurodegenerative diseaseInternal medicinemedicineDiagnostic biomarkerneurodegenerative diseasesproNGFimmunoassayOriginal Researchmedicine.diagnostic_testbusiness.industrySignificant differenceAlzheimer's diseaseLarge cohortdiagnosiImmunoassayBiomarker (medicine)biomarkerAutomated immunoassaybusinessRC321-571Neuroscience
researchProduct

Heterogeneity of P2-Purinoceptors in Brain Circulation

1990

The existence of P2-purinoceptors in the cerebrovascular bed was examined by testing the effects of ATP and its stable analog, α,β-methylene-ATP, on CBF in the unanesthetized goat as well as on isometric tension in isolated goat middle cerebral artery. When injected directly into the cerebral circulation, ATP increased and α,β-methylene-ATP decreased CBF. Indomethacin did not modify either of these effects. The vasoconstrictor action of α,β-methylene-ATP was reduced by nicardipine. “In vitro,” both ATP and α,β-methylene-ATP contracted the cerebral arteries at resting tone, but the analog was more potent than ATP. Repeated application of α,β-methylene-ATP as well as indomethacin significant…

P2Y receptorGoatsIndomethacinPurinergic receptorCerebral arteriesReceptors PurinergicCerebral ArteriesBiologyPharmacologyCerebral circulationAdenosine TriphosphateNeurologyVasoconstrictionCerebrovascular Circulationmedicine.arteryAnesthesiaMiddle cerebral arteryCirculatory systemmedicineAnimalsPotencyFemaleNeurology (clinical)Cardiology and Cardiovascular MedicineReceptorJournal of Cerebral Blood Flow & Metabolism
researchProduct